Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation

F Skjøth, TB Larsen, LH Rasmussen… - Thrombosis and …, 2014 - thieme-connect.com
Large Phase 3 clinical trials for stroke prevention in atrial fibrillation (AF) have compared
non-vitamin K antagonist oral anticoagulants (NOACs) against warfarin, with the edoxaban …
被引用次数：125 相关文章

Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis.

F Skjøth, TB Larsen, LH Rasmussen… - Thrombosis and …, 2014 - europepmc.org
Large Phase 3 clinical trials for stroke prevention in atrial fibrillation (AF) have compared
non-vitamin K antagonist oral anticoagulants (NOACs) against warfarin, with the edoxaban …

Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation

T Larsen, L Rasmussen, GYH Lip, F Skjøth - Thrombosis and …, 2014 - cir.nii.ac.jp
抄録< jats: title> Summary</jats: title>< jats: p> Large Phase 3 clinical trials for stroke
prevention in atrial fibrillation (AF) have compared non-vitamin K antagonist oral …
[PDF] mzsr.sk

[PDF][PDF] Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation

F Skjøth, TB Larsen, LH Rasmussen… - Thrombosis and …, 2014 - kategorizacia.mzsr.sk
Large Phase 3 clinical trials for stroke prevention in atrial fibrillation (AF) have compared
non-vitamin K antagonist oral anticoagulants (NOACs) against warfarin, with the edoxaban …

Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis

F Skjøth, TB Larsen, LH Rasmussen… - Thrombosis and …, 2014 - vbn.aau.dk
Large Phase 3 clinical trials for stroke prevention in atrial fibrillation (AF) have compared
non-vitamin K antagonist oral anticoagulants (NOACs) against warfarin, with the edoxaban …

Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation

F Skjøth, TB Larsen, LH Rasmussen… - Thrombosis and …, 2014 - thieme-connect.com
Large Phase 3 clinical trials for stroke prevention in atrial fibrillation (AF) have compared
non-vitamin K antagonist oral anticoagulants (NOACs) against warfarin, with the edoxaban …

[引用][C] Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: An indirect comparison …

F SKJØTH, TB LARSEN… - Thrombosis and …, 2014 - pascal-francis.inist.fr
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban
for stroke prevention in atrial fibrillation: An indirect comparison analysis CNRS Inist Pascal-Francis …

Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis

F Skjøth, TB Larsen… - Thrombosis and …, 2014 - pubmed.ncbi.nlm.nih.gov
Large Phase 3 clinical trials for stroke prevention in atrial fibrillation (AF) have compared
non-vitamin K antagonist oral anticoagulants (NOACs) against warfarin, with the edoxaban …